• 1
    Roberts LR. Sorafenib in liver cancer–just the beginning. New Engl J Med 2008; 359: 4202.
  • 2
    Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA-Cancer J Clin 2005; 55: 74108.
  • 3
    Poon RT, Fan ST, Wong J. Risk factors, prevention, and management of postoperative recurrence after resection of hepatocellular carcinoma. Ann Surg 2000; 232: 1024.
  • 4
    Wang W, Wu F, Fang F, Tao YM, Yang LY. Inhibition of invasion and metastasis of hepatocellular carcinoma cells via targeting RhoC in vitro and in vivo. Clin Cancer Res 2008; 14: 680412.
  • 5
    Wang W, Yang LY, Huang GW et al. Genomic analysis reveals RhoC as a potential marker in hepatocellular carcinoma with poor prognosis. Br J Cancer 2004; 90: 234955.
  • 6
    Chang ZG, Yang LY, Wang W et al. Determination of high mobility group A1 (HMGA1) expression in hepatocellular carcinoma: a potential prognostic marker. Dig Dis Sci 2005; 50: 176470.
  • 7
    Yang LY, Tao YM, Ou DP, Wang W, Chang ZG, Wu F. Increased expression of Wiskott–Aldrich syndrome protein family verprolin-homologous protein 2 correlated with poor prognosis of hepatocellular carcinoma. Clin Cancer Res 2006; 12: 56739.
  • 8
    Tateishi R, Shiina S, Yoshida H et al. Prediction of recurrence of hepatocellular carcinoma after curative ablation using three tumor markers. Hepatology 2006; 44: 151827.
  • 9
    Perl AK, Wilgenbus P, Dahl U, Semb H, Christofori G. A causal role for E-cadherin in the transition from adenoma to carcinoma. Nature 1998; 392: 1903.
  • 10
    Tsukita S, Furuse M, Itoh M. Multifunctional strands in tight junctions. Nat Rev Mol Cell Biol 2001; 2: 28593.
  • 11
    Bard F, Casano L, Mallabiabarrena A et al. Functional genomics reveals genes involved in protein secretion and Golgi organization. Nature 2006; 439: 6047.
  • 12
    Arlt D, Huber W, Liebel U et al. Functional profiling: from microarrays via cell-based assays to novel tumor relevant modulators of the cell cycle. Cancer Res 2005; 65: 773342.
  • 13
    Starkuviene V, Liebel U, Simpson JC et al. High-content screening microscopy identifies novel proteins with a putative role in secretory membrane traffic. Genome Res 2004; 14: 194856.
  • 14
    Sacchetti ML, Grasso D, Lo Re AE et al. Autophagy mediated by VMP1 expression is a survival mechanism in caerulein-treated AR42J pancreas cells. Gastroenterology 2008; 134: 429.
  • 15
    Pardo RP, Lo Re AE, Grasso D et al. The pancreatitis-induced membrane protein VMP1 that triggers autophagy interacts with S100A10. Gastroenterology 2008; 134(Suppl. 1): A2878.
  • 16
    Boer JM, Huber WK, Sültmann H et al. Identification and classification of differentially expressed genes in renal cell carcinoma by expression profiling on a global human 31500-element cDNA array. Genome Res 2001; 11: 186170.
  • 17
    Higgins JP, Shinghal R, Gill H et al. Gene expression patterns in renal cell carcinoma assessed by complementary DNA microarray. Am J Pathol 2003; 162: 92532.
  • 18
    Sauermann M, Sahin O, Sültmann H et al. Reduced expression of vacuole membrane protein 1 affects the invasion capacity of tumor cells. Oncogene 2008; 27: 13206.
  • 19
    Shimizu M, Saitoh Y, Itoh H. Immunohistochemical staining of Ha-ras oncogene product in normal, benign, and malignant human pancreatic tissues. Hum Pathol 1990; 21: 60712.
  • 20
    Ou DP, Tao YM, Tang FQ, Yang LY. The hepatitis B virus X protein promotes hepatocellular carcinoma metastasis by upregulation of matrix metalloproteinases. Int J Cancer 2007; 120: 120814.
  • 21
    Li Y, Tang Y, Ye L et al. Establishment of a hepatocellular carcinoma cell line with unique metastatic characteristics through in vivo selection and screening for metastasis-related genes through cDNA microarray. J Cancer Res Clin Oncol 2003; 129: 4351.
  • 22
    Li Y, Tian B, Yang J et al. Stepwise metastatic human hepatocellular carcinom a cell model system with multiple metastatic potentials established through consecutive in vivo selection and studies on metastatic characteristics. J Cancer Res Clin Oncol 2004; 130: 4608.
  • 23
    Arlt D, Sauermann M, Sahin O et al. The role of the transmembrane protein Vmp1 in the formation of cell–cell contacts. Eur J Cell Biol 2008; 87: 43.
  • 24
    Arlt D, Sauermann M, Sahin O et al. The invasion-suppressive function of the novel primordial junction protein Vmp1. Eur J Cell Biol 2007; 86: 39.
  • 25
    Christofori G. New signals from the invasive front. Nature 2006; 441: 44450.
  • 26
    Bannasch D, Mehrle A, Glatting KH, Pepperkok R, Poustka A, Wiemann S. LIFEdb: a database for functional genomics experiments integrating information from external sources, and serving as a sample tracking system. Nucleic Acids Res 2004; 32: 5058.
  • 27
    Calvo-Garrido J, Carilla-Latorre S, Lázaro-Diéguez F, Egea G, Escalante R. Vacuole membrane protein 1 is an endoplasmic reticulum protein required for organelle biogenesis, protein secretion, and development. Mol Biol Cell 2008; 19: 344253.
  • 28
    Calvo-Garrido J, Carilla-Latorre S, Escalante R. Vacuole membrane protein 1, autophagy and much more. Autophagy 2008; 4: 8357.
  • 29
    Ropolo A, Grasso D, Pardo R et al. The pancreatitis-induced vacuole membrane protein 1 triggers autophagy in mammalian cells. J Biol Chem 2007; 282: 3712433.
  • 30
    Yang LY, Fang F, Ou DP, Wu W, Zeng ZJ, Wu F. Solitary large hepatocellular carcinoma: a specific subtype of hepatocellular carcinoma with good outcome after hepatic resection. Ann Surg 2009; 249: 11823.
  • 31
    Dusetti NJ, Jiang Y, Vaccaro MI et al. Cloning and expression of the rat vacuole membrane protein 1 (VMP1), a new gene activated in pancreas with acute pancreatitis, which promotes vacuole formation. Biochem Biophys Res Commun 2002; 290: 6419.
  • 32
    Hirokawa T, Boon-Chieng S, Mitaku S. SOSUI: classification and secondary structure prediction system for membrane proteins. Bioinformatics 1998; 14: 3789.
  • 33
    Shin K, Fogg VC, Margolis B. Tight junctions and cell polarity. Annu Rev Cell Dev Biol 2006; 22: 20735.
  • 34
    Jamora C, Fuchs E. Intercellular adhesion, signalling and the cytoskeleton. Nat Cell Biol 2002; 4: 1018.
  • 35
    Bodemann BO, White MA. Ral GTPases and cancer: linchpin support of the tumorigenic platform. Nat Rev Cancer 2008; 8: 13340.
  • 36
    Martin TA, Watkins G, Mansel RE, Jiang WG. Loss of tight junction plaque molecules in breast cancer tissues is associated with a poor prognosis in patients with breast cancer. Eur J Cancer 2004; 40: 271725.
  • 37
    Kimmelman AC. The dynamic nature of autophagy in cancer. Genes Dev 2011; 25: 19992010.
  • 38
    Takamura A, Komatsu M, Hara T et al. Autophagy-deficient mice develop multiple liver tumors. Genes Dev 2011; 25: 795800.
  • 39
    Inami Y, Waguri S, Sakamoto A et al. Persistent activation of Nrf2 through p62 in hepatocellular carcinoma cells. J Cell Biol 2011; 193: 27584.
  • 40
    Mathew R, Karp CM, Beaudoin B et al. Autophagy suppresses tumorigenesis through elimination of p62. Cell 2009; 137: 106275.
  • 41
    Su Y, Qian H, Zhang J, Wang S, Shi P, Peng X. The diversity expression of p62 in digestive system cancers. Clin Immunol 2005; 116: 11823.
  • 42
    Itakura E, Mizushima N. p62 targeting to the autophagosome formation site requires self-oligomerization but not LC3 binding. J Cell Biol 2011; 192: 1727.
  • 43
    Komatsu M, Kurokawa H, Waguri S et al. The selective autophagy substrate p62 activates the stress responsive transcription factor Nrf2 through inactivation of Keap1. Nat Cell Biol 2010; 12: 21323.
  • 44
    Lau A, Wang XJ, Zhao F et al. A noncanonical mechanism of Nrf2 activation by autophagy deficiency: direct interaction between Keap1 and p62. Mol Cell Biol 2010; 30: 327585.
  • 45
    Martin TA, Jiang WG. Tight junctions and their role in cancer metastasis. Histol Histopathol 2001; 16: 118395.
  • 46
    Benoliel AM, Pirro N, Marin V et al. Correlation between invasiveness of colorectal tumor cells and adhesive potential under flow. Anticancer Res 2003; 23: 48916.